#BladderCancer Archives

Unveiling Progress in Immunotherapy and Pathological Diagnosis for Urological Cancers: Insights from Dr. Félix Guerrero Ramos and Dr. Xuefeng Qiu at EAU Congress 2024

By Mourabit Halima 2024.05.09

In a significant gathering at the European Association of Urology (EAU) Congress 2024, held in the vibrant city of Paris, two esteemed figures in the field of urology, Dr. Félix…

EAU24 Interview | Dr. Jens Bedke：Innovations in Advanced Urothelial Carcinoma Treatment

By Mourabit Halima 2024.04.29

Editor's note: Platinum-based chemotherapy remains the cornerstone of treatment for advanced urothelial cancer (UC), but it still does not meet the long-term survival needs of patients; the 39th European Association…

ESMO Highlights | Professor Wei Yu’s Commentary on Advances in Neoadjuvant Therapy and Bladder Preservation in Bladder Cancer

By Lisa Cui 2024.01.19

Editor's Note: Bladder cancer is a common tumor in the urinary system, with muscle-invasive bladder cancer (MIBC) accounting for approximately 20% of all bladder cancers. Nearly half of non-muscle-invasive bladder…